54 results
Page 2 of 3
D
mpm0wla5qeee2jjoudmo
4 Nov 21
Indefinite amount in equity, sold $67.26K, 6 investors
4:20pm
8-K
EX-2.1
bxa2 w6ikcv1abrsa9a
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
D
wlbb3jp jor6zm
23 Aug 21
$10.75M in options / securities to be acquired, sold $10.75M, 14 investors
4:15pm
8-K
EX-10.1
0d2dzu iecpse
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
D
7y8nu1qhbzb6dkucym90
21 Jan 21
$8M in equity / options / securities to be acquired, sold $8M, 1 investor
4:15pm
8-K
EX-10.1
vw197z
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
D
xuxy8niv4fu5dpz5 v8
4 Jan 21
Indefinite amount in equity, sold $3.2M, 15 investors
12:00am
8-K
EX-2.1
mtoh1s
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
D
yllmmu
15 Jan 20
Indefinite amount in options / securities to be acquired, 5 investors
4:15pm
8-K
EX-10.1
ky10y1 9gr6f2qs
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
D
adq9piufv3hsxeml22hm
8 Oct 19
$1.88M in equity / options / securities to be acquired, sold $1.88M, 1 investor
4:06pm
8-K
EX-10.1
11nhz8go33nte1rysf3
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-10.1
qzeno0x83u
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am